Literature DB >> 20720572

Antihypertensive treatment and control in a large primary care population of 21 167 patients.

M Qvarnström1, B Wettermark, C Ljungman, R Zarrinkoub, J Hasselström, K Manhem, A Sundström, T Kahan.   

Abstract

The efficacy of antihypertensive drug therapy is undisputed, but observational studies show that few patients reach a target blood pressure <140/90 mm Hg. However, there is limited data on the drug prescribing patterns and their effectiveness in real practice. This retrospective observational survey of electronic patient records extracted data from 24 Swedish primary health-care centres, with a combined registered population of 330 000 subjects. We included all patients > 30 years with a recorded diagnosis of hypertension who consulted the centres in 2005 or 2006 (n=21 167). Main outcome measures were systolic and diastolic blood pressures, and prescribed antihypertensive drug classes. Only 27% had a blood pressure <140/90 mm Hg. The number of prescribed drugs increased with age, except among the oldest (> 90 years). Only 29% of patients given monotherapy had a blood pressure <140/90 mm Hg. Women more often received diuretics (52 vs 42%), and less often angiotensin-converting enzyme inhibitors (22 vs 33%) and calcium channel blockers (26 vs 31%) than men. β-Blockers and diuretics were the most common drug classes prescribed, independent of comorbidity. In conclusion, one out of four primary care patients with hypertension reach target blood pressure. More frequent use of drug combinations may improve blood pressure control.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20720572     DOI: 10.1038/jhh.2010.86

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  12 in total

Review 1.  Guest Editorial Challenges in Resistant Hypertension.

Authors:  Thomas Kahan
Journal:  Eur Cardiol       Date:  2016-08

2.  Persistence to antihypertensive drug treatment in Swedish primary healthcare.

Authors:  Miriam Qvarnström; Thomas Kahan; Helle Kieler; Lena Brandt; Jan Hasselström; Kristina Bengtsson Boström; Karin Manhem; Per Hjerpe; Björn Wettermark
Journal:  Eur J Clin Pharmacol       Date:  2013-07-16       Impact factor: 2.953

3.  Antihypertensive treatment and control according to gender, education, country of birth and psychiatric disorder: the Swedish Primary Care Cardiovascular Database (SPCCD).

Authors:  C Ljungman; T Kahan; L Schiöler; P Hjerpe; B Wettermark; K B Boström; K Manhem
Journal:  J Hum Hypertens       Date:  2014-11-06       Impact factor: 3.012

4.  A titrate-to-goal study of switching patients uncontrolled on antihypertensive monotherapy to fixed-dose combinations of amlodipine and olmesartan medoxomil ± hydrochlorothiazide.

Authors:  Matthew R Weir; Willa A Hsueh; Shawna D Nesbitt; Thomas J Littlejohn; Alan Graff; Ali Shojaee; William F Waverczak; Chunlin Qian; Christopher J Jones; Joel M Neutel
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-02-05       Impact factor: 3.738

5.  Integrated control of hypertension by olmesartan medoxomil and hydrochlorothiazide and rationale for combination.

Authors:  Henry A Punzi
Journal:  Integr Blood Press Control       Date:  2011-12-07

6.  Long term trends in control of hypertension in the Northern Sweden MONICA study 1986-2009.

Authors:  Ellinor Törmä; Bo Carlberg; Marie Eriksson; Jan-Håkan Jansson; Mats Eliasson
Journal:  BMC Public Health       Date:  2015-09-24       Impact factor: 3.295

7.  Persistence to antihypertensive drug classes: A cohort study using the Swedish Primary Care Cardiovascular Database (SPCCD).

Authors:  Miriam Qvarnström; Thomas Kahan; Helle Kieler; Lena Brandt; Jan Hasselström; Kristina Bengtsson Boström; Karin Manhem; Per Hjerpe; Björn Wettermark
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

8.  Sex differences in spontaneous reports on adverse drug events for common antihypertensive drugs.

Authors:  Diana M Rydberg; Stefan Mejyr; Desirée Loikas; Karin Schenck-Gustafsson; Mia von Euler; Rickard E Malmström
Journal:  Eur J Clin Pharmacol       Date:  2018-05-27       Impact factor: 2.953

9.  Multimorbidity and blood pressure control in 37 651 hypertensive patients from Danish general practice.

Authors:  Maja S Paulsen; Morten Andersen; Janus L Thomsen; Henrik Schroll; Pia V Larsen; Jesper Lykkegaard; Ib A Jacobsen; Mogens L Larsen; Bo Christensen; Jens Sondergaard
Journal:  J Am Heart Assoc       Date:  2012-12-31       Impact factor: 5.501

10.  Improved Blood Pressure Control Using an Interactive Mobile Phone Support System.

Authors:  Ulrika Bengtsson; Karin Kjellgren; Inger Hallberg; Magnus Lindwall; Charles Taft
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-10-12       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.